2813-3064

Sclerosis

MDPI AG

View prefix report (10.3390)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 1 article

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact1 DOIs

DOIs for this ISSN

Showing the top 5 of 99 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Benign COVID-19 in an Aggressive Case of Aquaporin-4 Neuromy… (10.3390/sclerosis1010001)
0.00 1
2 Anti-Yo Paraneoplastic Cerebellar Degeneration and Breast Ca… (10.3390/sclerosis1010002)
0.00 3
3 Multiple Sclerosis and Sodium Toxicity: Controversy and Futu… (10.3390/sclerosis1010003)
0.00 4
4 COQ7-Related Juvenile-Onset Motor Neuronopathy: A New Pathog… (10.3390/sclerosis1010004)
0.00 2
5 A Pilot Randomised Control Trial of an Online Acceptance and… (10.3390/sclerosis1010005)
0.00 11
6 Is It Lupus? Is It Neuromyelitis Optica Spectrum Disorder (N… (10.3390/sclerosis1010006)
0.00 1
7 Isolated Myelopathy in Occult Breast Carcinoma with Negative… (10.3390/sclerosis1010007)
0.00 0
8 Publisher’s Note: Sclerosis—A New Open Access Journal (10.3390/sclerosis1010008)
0.00 0
9 Immersive Virtual Reality to Improve Functional Capacities i… (10.3390/sclerosis1020009)
0.00 2
10 Quality of Life in Multiple Sclerosis: The Predictive Roles… (10.3390/sclerosis1020010)
0.00 3
11 Roles of Extracellular Vesicles in Multiple Sclerosis: From… (10.3390/sclerosis1020011)
0.00 12
12 Impacts of Air Pollution and Thermal Discomfort in Hospitali… (10.3390/sclerosis1030012)
0.00 2
13 Relationship between MRI Findings and Urodynamic Parameters… (10.3390/sclerosis1030013)
0.00 1
14 Digital Biomarkers in the Assessment of Mobility in Individu… (10.3390/sclerosis1030014)
0.00 3
15 Dissipation of Motor Sleep Inertia and Motor Wake Inertia in… (10.3390/sclerosis2010001)
0.00 0
16 Anti-CD20-Triggered Crohn’s-Like Disease with Severe Periana… (10.3390/sclerosis2010002)
0.00 0
17 Mapping the Therapeutic Options for Multiple Sclerosis in Br… (10.3390/sclerosis2010003)
0.00 1
18 Role of Smartphone Applications in the Assessment and Manage… (10.3390/sclerosis2010004)
0.00 0
19 Contextual Factors Matter: The Role of Social Support in Wor… (10.3390/sclerosis2010005)
0.00 3
20 Risk Factors for Cognitive Impairment in Multiple Sclerosis… (10.3390/sclerosis2020006)
0.00 3
21 Current and Emerging Treatment Options in Pediatric Onset Mu… (10.3390/sclerosis2020007)
0.00 10
22 The Cognitive Reserve May Influence Fatigue after Rehabilita… (10.3390/sclerosis2020008)
0.00 0
23 Multiple Sclerosis: Immune Cells, Histopathology, and Therap… (10.3390/sclerosis2030009)
0.00 9
24 Elucidating the Epigenetic and Protein Interaction Landscape… (10.3390/sclerosis2030010)
0.00 3
25 Diet-Induced Changes in Functional Disability among People w… (10.3390/sclerosis2030011)
0.00 1
26 Biomarkers Differentiating RRMS and SPMS in Multiple Scleros… (10.3390/sclerosis2030012)
0.00 6
27 Pseudobulbar Affect in Patients with Multiple Sclerosis: A S… (10.3390/sclerosis2030013)
0.00 1
28 Lung Involvement in Systemic Sclerosis—From Pathogenesis to… (10.3390/sclerosis2030014)
0.00 0
29 Anti-Inflammatory Benefits of Vitamin D and Its Analogues ag… (10.3390/sclerosis2030015)
0.00 8
30 Assessing the Relationship between Personality Traits and Cl… (10.3390/sclerosis2030016)
0.00 1
31 Burden in Multiple Sclerosis Caregivers: A Single-Center Exp… (10.3390/sclerosis2030017)
0.00 0
32 A Narrative Review of Therapeutic Options in Systemic Sclero… (10.3390/sclerosis2040018)
0.00 2
33 Insights and Future Perspectives in Calcinosis Cutis Associa… (10.3390/sclerosis2040019)
0.00 0
34 Multiple Sclerosis and Subcutaneous Panniculitis-like T Cell… (10.3390/sclerosis2040020)
0.00 0
35 Preclinical and Clinical Data on Current Therapeutic Options… (10.3390/sclerosis2040021)
0.00 1
36 Resilience, Mental Health, Sleep, and Smoking Mediate Pathwa… (10.3390/sclerosis2040022)
0.00 1
37 The Conjecture of Poser on the Origins of Multiple Sclerosis… (10.3390/sclerosis2040023)
0.00 0
38 A 2-Year Longitudinal Neuropsychological Study in Relapsing-… (10.3390/sclerosis2040024)
0.00 0
39 The Road Well Traveled: From Inflammasomes to Collagen Expor… (10.3390/sclerosis2040025)
0.00 2
40 Lifestyle, Cognition, and Disability Outcomes in Multiple Sc… (10.3390/sclerosis2040026)
0.00 1
41 High-Fat Diet—Shared Environmental Risk Factor for Amyotroph… (10.3390/sclerosis3010001)
0.00 0
42 Efficacy and Immunological Impact of Intrathecal Baclofen Pu… (10.3390/sclerosis3010002)
0.00 2
43 The Use of Augmented Reality on a Self-Paced Treadmill to Qu… (10.3390/sclerosis3010003)
0.00 2
44 The Impact of α-Lipoic Acid Treatment on Multiple Sclerosis… (10.3390/sclerosis3010004)
0.00 4
45 B-Cell-Depleting Immune Therapies as Potential New Treatment… (10.3390/sclerosis3010005)
0.00 4
46 From Gene to Clinic: The Role of APOL1 in Focal Segmental Gl… (10.3390/sclerosis3010006)
0.00 2
47 Uncovering Subclinical Cardiac Involvement in VEDOSS: An Ech… (10.3390/sclerosis3010007)
0.00 2
48 Microbial Influences on Amyotrophic Lateral Sclerosis: The G… (10.3390/sclerosis3010008)
0.00 12
49 Biomarker Identification in Patients with Multiple Sclerosis… (10.3390/sclerosis3020009)
0.00 0
50 Health Locus of Control and Its Relationship with Quality of… (10.3390/sclerosis3020010)
0.00 0